Recon: FDA inspectors cited Neuralink for animal testing issues; Fake weight loss drugs worry FDA chief

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States